[(2S)-4-[1-[6-(5-fluoro-2-methylphenyl)-5-(trifluoromethyl)-2-pyridinyl]-2H-pyridin-6-yl]piperazin-2-yl]methanol
C23H24F4N4O — CID 151636910
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2S)-4-[1-[6-(5-fluoro-2-methylphenyl)-5-(trifluoromethyl)-2-pyridinyl]-2H-pyridin-6-yl]piperazin-2-yl]methanol
[(2S)-4-[1-[6-(5-fluoro-2-methylphenyl)-5-(trifluoromethyl)-2-pyridinyl]-2H-pyridin-6-yl]piperazin-2-yl]methanol (PubChem CID 151636910) has the molecular formula C23H24F4N4O and a molecular weight of 448.46 g/mol. Its IUPAC name is [(2S)-4-[1-[6-(5-fluoro-2-methylphenyl)-5-(trifluoromethyl)-2-pyridinyl]-2H-pyridin-6-yl]piperazin-2-yl]methanol.
Molecular Properties
| Compound Name | [(2S)-4-[1-[6-(5-fluoro-2-methylphenyl)-5-(trifluoromethyl)-2-pyridinyl]-2H-pyridin-6-yl]piperazin-2-yl]methanol |
|---|---|
| PubChem CID | 151636910 |
| Molecular Formula | C23H24F4N4O |
| Molecular Weight | 448.46 g/mol |
| Exact Mass | 448.19 |
| IUPAC Name | [(2S)-4-[1-[6-(5-fluoro-2-methylphenyl)-5-(trifluoromethyl)-2-pyridinyl]-2H-pyridin-6-yl]piperazin-2-yl]methanol |
| SMILES | Cc1ccc(F)cc1-c1nc(N2CC=CC=C2N2CCN[C@H](CO)C2)ccc1C(F)(F)F |
| InChI | InChI=1S/C23H24F4N4O/c1-15-5-6-16(24)12-18(15)22-19(23(25,26)27)7-8-20(29-22)31-10-3-2-4-21(31)30-11-9-28-17(13-30)14-32/h2-8,12,17,28,32H,9-11,13-14H2,1H3/t17-/m0/s1 |
| InChIKey | QRRVBKAMJJHGGT-KRWDZBQOSA-N |
| XLogP | 3.70 |
| TPSA | 51.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 448.46 |
| LogP ≤ 5 | 3.70 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151636910 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.